US Patent 7423024 Recombinant human alpha-fetoprotein as an immunosuppressive agent
Patent 7423024 was granted and assigned to Merrimack Pharmaceuticals on September, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 4, 2004
Date of Patent
September 9, 2008
Patent Application Number
10838476
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7423024 Recombinant human alpha-fetoprotein as an immunosuppressive agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.